Last reviewed · How we verify
NCT03068806
Brain Imaging, Attention, and Auditory Processing in Schizophrenia
trial testing Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI) in Schizophrenia in 202 participants. Completed in 11 May 2018.
11 May 2018
Quick facts
| Lead sponsor | San Francisco Veterans Affairs Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 202 |
| Start date | 1 December 2014 |
| Primary completion | 11 May 2018 |
| Estimated completion | 11 May 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)
Conditions studied
- Schizophrenia — all drugs for Schizophrenia →
Sponsor
San Francisco Veterans Affairs Medical Center
Who can join
Adults 18 to 75, any sex, with Schizophrenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a research study designed to examine how the psychiatric illness called schizophrenia affects brain function and thinking abilities such as attention and memory during simple computer-based tasks, and how measures of brain function are related to performance. The investigators do this by looking at brain activity using electroencephalography (EEG) and magnetic resonance imaging (MRI). The investigators compare participants' results to the activity in their brain as well as clinical measures and questionnaires also completed during this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03068806
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI)
Trials testing the same drug.
- NCT03758495 — Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functiona · withdrawn
- NCT03068793 — Reward Processing in Mental Illness · completed
Other recruiting trials for Schizophrenia
Currently open trials in the same condition.
- NCT07424404 — A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au · Phase 3 · recruiting
- NCT07467993 — Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia · Phase 2 · recruiting
- NCT07379827 — Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · recruiting
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
Other San Francisco Veterans Affairs Medical Center trials
Trials by the same sponsor.
- NCT05194098 — Using Electrophysiology to Index Non-invasive Brain Stimulation Effects on Reward System Functioning in Depression · NA · recruiting
- NCT06208943 — Neural and Cognitive Consequences of COVID-19 Survival · recruiting
- NCT06080646 — Reward Processing and Depressive Subtypes: Identifying Neural Biotypes · recruiting
- NCT04330365 — Pragmatic Trial of WHT vs. PC-GE to Promote Non-Pharmacological Strategies to Treat Chronic Pain in Veterans · NA · completed
- NCT04413643 — NIV for COPD: Hospital to Home · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03068806 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by San Francisco Veterans Affairs Medical Center
- Last refreshed: 30 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03068806.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing